Article
Therapeutic targeting of human hepatocyte growth factor with a single neutralizing monoclonal antibody reduces lung tumorigenesis.
Molecular cancer therapeutics - 1 Jul 2008
Stabile Laura P, Rothstein Mary E, Keohavong Phouthone, Jin Jide, Yin Jinling, Land Stephanie R, Dacic Sanja, Luong The Minh, Kim K Jin, Dulak Austin M, Siegfried Jill M
Abstract excerpt
The hepatocyte growth factor (HGF)/c-Met signaling pathway is involved in lung tumor growth and progression, and agents that target this pathway have clinical potential for lung cancer treatment. L2G7, a single potent anti-human HGF neutralizing monoclonal antibody, showed profound inhibition of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
